jte 522 has been researched along with Hepatocellular Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, R; Fujise, Y; Murawaki, Y; Nagahara, T; Okano, J | 1 |
| Murawaki, Y; Nagahara, T; Okano, J | 1 |
2 other study(ies) available for jte 522 and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Preventive effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on DEN-induced hepatocarcinogenesis in rats.
Topics: Animals; Apoptosis; Benzenesulfonates; Blotting, Western; Carcinoma, Hepatocellular; Cell Proliferation; Chemoprevention; Cyclooxygenase 2 Inhibitors; Diethylnitrosamine; Gene Expression Regulation, Neoplastic; Glutathione Transferase; In Situ Nick-End Labeling; Liver Neoplasms, Experimental; Male; Oxazoles; Oxidative Stress; Proliferating Cell Nuclear Antigen; Rats; Rats, Wistar; Time Factors | 2010 |
Mechanisms of anti-proliferative effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on human liver cancer cells.
Topics: Apoptosis; Benzenesulfonates; Carcinoma, Hepatocellular; Caspases; Cell Proliferation; Cyclin D; Cyclin E; Cyclin-Dependent Kinase Inhibitor p27; Cyclins; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Humans; Liver Neoplasms; Mitogen-Activated Protein Kinases; Oncogene Proteins; Oxazoles; PPAR gamma; Tumor Cells, Cultured | 2007 |